Amsterdam Life Sciences Cafe: AI and data in drug development and diagnostics

This edition we will focus on AI & data in drug development and diagnostics. Digital transformation in healthcare is taking an increasingly prominent role in the development of therapeutics and diagnostics. Register here!

Artificial Intelligence, machine learning, data and digital technologies are applied to accelerate drug development and improve patient diagnosis and treatment options. The aim is to deliver life-changing therapies and diagnostics faster and more personalized. In this edition, two companies, Agendia and IQVIA, will present how they use the potential of AI & data.

It promises to be an exciting get-together, with an extra warm welcome to those Life Sciences companies looking to make the next step.

• The event will feature two speakers:
  Martijn Nap (IQVIA) will talk about the use of AI for clinical trials.
  Bastiaan van der Baan (Agendia) will enlighten us about the transition from molecular determination to AI-based analysis of medical imaging.
  Walk-in: 3.30 PM, Start: 4.00 PM
• About Amsterdam Life Sciences Café’s
  Together with EY The Amsterdam Economic Board organises the Amsterdam Life Sciences Café’s. These meet-ups are aimed at bringing together colleagues from the life sciences sector, business, health innovators, researchers and knowledge institutions in the field of health and prevention. Designed to share knowledge, new research and innovative applications.